Research over the past decade has revealed that MMPs can promote chemical resistance and tumour progression through proteolytic inactivation of the cell receptor Fas and subsequent inhibition of internal apoptosis; preventing the separation of Fas by MMPs is a therapeutic intervention30. Here, FAS is linked to neoplasm.